1. Home
  2. CGEN vs PCQ Comparison

CGEN vs PCQ Comparison

Compare CGEN & PCQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGEN
  • PCQ
  • Stock Information
  • Founded
  • CGEN 1993
  • PCQ 2001
  • Country
  • CGEN Israel
  • PCQ United States
  • Employees
  • CGEN N/A
  • PCQ N/A
  • Industry
  • CGEN Biotechnology: Biological Products (No Diagnostic Substances)
  • PCQ Investment Managers
  • Sector
  • CGEN Health Care
  • PCQ Finance
  • Exchange
  • CGEN Nasdaq
  • PCQ Nasdaq
  • Market Cap
  • CGEN 167.4M
  • PCQ 156.8M
  • IPO Year
  • CGEN 2000
  • PCQ N/A
  • Fundamental
  • Price
  • CGEN $1.45
  • PCQ $8.47
  • Analyst Decision
  • CGEN
  • PCQ
  • Analyst Count
  • CGEN 0
  • PCQ 0
  • Target Price
  • CGEN N/A
  • PCQ N/A
  • AVG Volume (30 Days)
  • CGEN 206.7K
  • PCQ 69.6K
  • Earning Date
  • CGEN 08-06-2025
  • PCQ 01-01-0001
  • Dividend Yield
  • CGEN N/A
  • PCQ 4.63%
  • EPS Growth
  • CGEN N/A
  • PCQ N/A
  • EPS
  • CGEN N/A
  • PCQ N/A
  • Revenue
  • CGEN $22,144,000.00
  • PCQ N/A
  • Revenue This Year
  • CGEN N/A
  • PCQ N/A
  • Revenue Next Year
  • CGEN $159.40
  • PCQ N/A
  • P/E Ratio
  • CGEN N/A
  • PCQ N/A
  • Revenue Growth
  • CGEN N/A
  • PCQ N/A
  • 52 Week Low
  • CGEN $1.13
  • PCQ $8.19
  • 52 Week High
  • CGEN $2.66
  • PCQ $10.50
  • Technical
  • Relative Strength Index (RSI)
  • CGEN 48.38
  • PCQ 73.16
  • Support Level
  • CGEN $1.39
  • PCQ $8.23
  • Resistance Level
  • CGEN $1.46
  • PCQ $8.28
  • Average True Range (ATR)
  • CGEN 0.06
  • PCQ 0.06
  • MACD
  • CGEN 0.00
  • PCQ 0.03
  • Stochastic Oscillator
  • CGEN 52.63
  • PCQ 96.84

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

About PCQ PIMCO California Municipal Income Fund

PIMCO California Municipal Income Fund is a closed-end management investment company. It seeks to provide current income exempt from federal and California income tax. The fund makes investments in different sectors such as healthcare, property, education, Natural Gas, and others.

Share on Social Networks: